Your browser doesn't support javascript.
loading
The role of quantitative tumor burden based on [68 Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis.
Chen, Luohai; Jumai, Nuerailaguli; He, Qiao; Liu, Man; Lin, Yuan; Luo, Yanji; Wang, Yu; Chen, Min-Hu; Zeng, Zhirong; Zhang, Xiangsong; Zhang, Ning.
  • Chen L; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Jumai N; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • He Q; Department of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Liu M; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Lin Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Luo Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Wang Y; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Chen MH; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zeng Z; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhang X; Department of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. zhxiangs@mail.sysu.edu.cn.
  • Zhang N; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. zhangn5@mail.sysu.edu.cn.
Eur J Nucl Med Mol Imaging ; 50(2): 525-534, 2023 01.
Article en En | MEDLINE | ID: mdl-36181533

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article